Filing Details

Accession Number:
0001415889-23-003727
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-01 21:05:31
Reporting Period:
2023-02-27
Accepted Time:
2023-03-01 21:05:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1350653 Alphatec Holdings Inc. ATEC Surgical & Medical Instruments & Apparatus (3841) 202463898
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1831608 Scott Lish C/O Alphatec Spine, Inc.
1950 Camino Vida Roble
Carlsbad CA 92008
Svp, Development No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-02-27 25,372 $14.76 430,522 No 4 S Direct
Common Stock Acquisiton 2023-03-01 13,493 $3.50 444,015 No 4 M Direct
Common Stock Disposition 2023-03-01 2,924 $16.15 441,091 No 4 F Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 M Direct
No 4 F Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrants (right to buy) Disposition 2023-03-01 13,493 $0.00 13,493 $3.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2018-05-17 2023-05-17 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2022, to satisfy certain tax withholding obligations of the reporting person resulting from the vesting of restricted stock units.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.51 to $14.94, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. Includes 2,034 shares and 826 shares acquired under the issuer's employee stock purchase plan on May 13, 2022 and November 15, 2022, respectively.
  4. On March 1, 2023, the reporting person exercised warrants to purchase 13,493 shares of the issuer's common stock for $3.50 per share. The reporting person paid the exercise price on a cashless basis, resulting in the issuer withholding 2,924 of the warrant shares to pay the exercise price and issuing to the reporting person 10,569 shares.